🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective was: \- to assess the bioequivalence of a single dos...
Status
Completed
Location
Quotient Clinical Ltd
Start Date
2014-09
Trial ID
NCT02237508
This Phase IV study is an a multi-centre, randomised open label, two way cr...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-11-14
Trial ID
NCT02233803
The primary purpose of this study is to demonstrate the equivalence of bude...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-10-17
Trial ID
NCT06340581
A phase III study, multicenter, randomized, parallel, open, two-period, com...
Status
Completed
Location
Eurofarma Laboratorios S.A
Start Date
2023-04-19
Trial ID
NCT04233190
Treatments Being Tested
This study will evaluate whether prompt initiation and maintenance of Brezt...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-01-19
Trial ID
NCT05970263
The purpose of this study is to determine whether Symbicort dosed according...
Status
Completed
Location
Research Site
Start Date
2004-12
Trial ID
NCT00252863
Treatments Being Tested
The purpose of this study is to investigate the effect of combined treatmen...
Status
Completed
Location
Research Site
Start Date
2007-05
Trial ID
NCT00496470
Treatments Being Tested
The goal of this clinical trial is to determine if triple inhaled therapy w...
Status
Completed
Location
Narongkorn Saiphoklang
Start Date
2025-04-01
Trial ID
NCT06905483
Treatments Being Tested
Patients with chronic obstructive pulmonary disease (COPD) have elevated ri...
Status
Completed
Location
AstraZeneca
Start Date
2024-02-29
Trial ID
NCT06744374
The fixed-dose combination product Budesonide/Glycopyrronium/Formoterol Fum...
Status
Unknown
Location
Guangzhou Institute of Respiratory Diseases
Start Date
2020-12-30
Trial ID
NCT04675463
Treatments Being Tested